The Effect of the MedSentry System on Medication Adherence



Status:Completed
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:5/5/2014
Start Date:March 2013
End Date:September 2013
Contact:Ellen Murachver
Email:EMURACHVER@PARTNERS.ORG
Phone:(617) 643-0272

Use our guide to learn which trials are right for you!

The Effect of the MedSentry System on Medication Adherence for Patients With Congestive Heart Failure: A Pilot Study

The goal of this pilot study to evaluate the effect of the MedSentry system, a multi-faceted
medication adherence device and reminder system, on medication adherence and clinical
outcomes in heart-failure (HF) patients. We will also evaluate the usability and
satisfaction derived from using this system.

We hypothesize that:

1. The use of the MedSentry system will improve medication adherence in patients with a
discharge diagnosis of HF.

2. The improvement in adherence correlates with fewer inpatient hospitalizations.

3. The improvement in adherence correlates with better health-related quality of life.


Inclusion Criteria:

- Patients who have successfully completed the Partners Connected Cardiac Care Program
(CCCP)

- Take at least 3 and no more than 10 different daily medications (including both
prescription and non-prescription/over the counter medications) to treat Heart
Failure (HF) and other comorbid disorders.

- Take medications no more than 4 specified times each day (i.e. morning, afternoon,
early evening, bedtime).

- The patient must be able to open a pill bottle independently.

- The patient must be able to sort and manage their own medications.

- Hospitalization within the last 24 months.

- Have a telephone or cell phone.

- Live in the greater Boston area.

- The patients must speak, read and write English.

- The patients must not be either vision or hearing impaired (i.e., unable to hear an
alarm similar to a clock alarm or oven alarm).

- Patient must have an Massachusetts General Hospital (MGH) affiliated care provider.

Exclusion Criteria:

- Dementia or other conditions precluding the participant from providing informed
consent or from learning to use the MedSentry pillbox.

- Home environment unsuitable for the MedSentry pillbox and other installed equipment.

- Awaiting revascularization, cardiac resynchronization or heart transplant.

- Patients with a coexisting terminal illness like cancer or Chronic Renal Failure
(CRF) requiring dialysis.
We found this trial at
1
site
185 Cambridge Street
Boston, Massachusetts 02114
617-724-5200
?
mi
from
Boston, MA
Click here to add this to my saved trials